Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 224

1.

Comparison of change in coronary atherosclerosis in patients with stable versus unstable angina pectoris receiving statin therapy (from the Treatment With Statin on Atheroma Regression Evaluated by Intravascular Ultrasound With Virtual Histology [TRUTH] study).

Nozue T, Yamamoto S, Tohyama S, Fukui K, Umezawa S, Onishi Y, Kunishima T, Sato A, Nozato T, Miyake S, Takeyama Y, Morino Y, Yamauchi T, Muramatsu T, Hibi K, Terashima M, Michishita I; TRUTH Investigators.

Am J Cardiol. 2013 Apr 1;111(7):923-9. doi: 10.1016/j.amjcard.2012.12.008. Epub 2013 Jan 18.

PMID:
23337838
2.

Impacts of estimated glomerular filtration rate on coronary atherosclerosis and plaque composition before and during statin therapy in patients with normal to mild renal dysfunction: subanalysis of the TRUTH study.

Nozue T, Yamamoto S, Tohyama S, Fukui K, Umezawa S, Onishi Y, Kunishima T, Hibi K, Terashima M, Michishita I; TRUTH INVESTIGATORS.

Nephrology (Carlton). 2012 Sep;17(7):628-35. doi: 10.1111/j.1440-1797.2012.01628.x.

PMID:
22708952
3.

Comparison of arterial remodeling and changes in plaque composition between patients with progression versus regression of coronary atherosclerosis during statin therapy (from the TRUTH study).

Nozue T, Yamamoto S, Tohyama S, Fukui K, Umezawa S, Onishi Y, Kunishima T, Sato A, Nozato T, Miyake S, Takeyama Y, Morino Y, Yamauchi T, Muramatsu T, Hibi K, Terashima M, Michishita I; TRUTH Investigators.

Am J Cardiol. 2012 May 1;109(9):1247-53. doi: 10.1016/j.amjcard.2011.12.016. Epub 2012 Feb 9.

PMID:
22325089
4.

Reverse vessel remodeling but not coronary plaque regression could predict future cardiovascular events in ACS patients with intensive statin therapy--the extended JAPAN-ACS study.

Miyauchi K, Daida H, Morimoto T, Hiro T, Kimura T, Nakagawa Y, Yamagishi M, Ozaki Y, Kadota K, Kimura K, Hirayama A, Kimura K, Hasegawa Y, Uchiyama S, Matsuzaki M; JAPAN-ACS Investigators.

Circ J. 2012;76(4):825-32.

5.

Effects of serum n-3 to n-6 polyunsaturated fatty acids ratios on coronary atherosclerosis in statin-treated patients with coronary artery disease.

Nozue T, Yamamoto S, Tohyama S, Fukui K, Umezawa S, Onishi Y, Kunishima T, Sato A, Nozato T, Miyake S, Takeyama Y, Morino Y, Yamauchi T, Muramatsu T, Hibi K, Terashima M, Michishita I.

Am J Cardiol. 2013 Jan 1;111(1):6-11. doi: 10.1016/j.amjcard.2012.08.038. Epub 2012 Oct 2.

PMID:
23040588
6.

Comparison of the effects of pitavastatin versus pravastatin on coronary artery plaque phenotype assessed by tissue characterization using serial virtual histology intravascular ultrasound.

Nozue T, Yamamoto S, Tohyama S, Fukui K, Umezawa S, Onishi Y, Kunishima T, Sato A, Nozato T, Miyake S, Takeyama Y, Morino Y, Yamauchi T, Muramatsu T, Hibi K, Terashima M, Michishita I.

Heart Vessels. 2015 Jan;30(1):36-44. doi: 10.1007/s00380-013-0453-8. Epub 2013 Dec 15.

PMID:
24337500
7.

Statin treatment for coronary artery plaque composition based on intravascular ultrasound radiofrequency data analysis.

Nozue T, Yamamoto S, Tohyama S, Umezawa S, Kunishima T, Sato A, Miyake S, Takeyama Y, Morino Y, Yamauchi T, Muramatsu T, Hibi K, Sozu T, Terashima M, Michishita I.

Am Heart J. 2012 Feb;163(2):191-9.e1. doi: 10.1016/j.ahj.2011.11.004.

PMID:
22305836
8.

Treatment with statin on atheroma regression evaluated by intravascular ultrasound with Virtual Histology (TRUTH Study): rationale and design.

Nozue T, Yamamoto S, Tohyama S, Umezawa S, Kunishima T, Sato A, Miyake S, Takeyama Y, Morino Y, Yamauchi T, Muramatsu T, Hibi K, Sozu T, Michishita I; Kanagawa PTCA Conference Study Group.

Circ J. 2009 Feb;73(2):352-5. Epub 2008 Dec 26.

9.

C-reactive protein and future cardiovascular events in statin-treated patients with angina pectoris: the extended TRUTH study.

Nozue T, Fukui K, Yamamoto S, Kunishima T, Umezawa S, Onishi Y, Tohyama S, Takeyama Y, Morino Y, Yamauchi T, Hibi K, Sozu T, Terashima M, Michishita I; TRUTH Investigators.

J Atheroscler Thromb. 2013;20(9):717-25. Epub 2013 Jun 8.

10.

Low serum docosahexaenoic acid is associated with progression of coronary atherosclerosis in statin-treated patients with diabetes mellitus: results of the treatment with statin on atheroma regression evaluated by intravascular ultrasound with virtual histology (TRUTH) study.

Nozue T, Yamamoto S, Tohyama S, Fukui K, Umezawa S, Onishi Y, Kunishima T, Sato A, Nozato T, Miyake S, Takeyama Y, Morino Y, Yamauchi T, Muramatsu T, Hibi K, Terashima M, Michishita I.

Cardiovasc Diabetol. 2014 Jan 13;13:13. doi: 10.1186/1475-2840-13-13.

11.

Time course of statin-induced changes in coronary atherosclerosis using intravascular ultrasound with virtual histology.

Nozue T, Fukui K, Yamamoto S, Kunishima T, Umezawa S, Onishi Y, Tohyama S, Hibi K, Sozu T, Terashima M, Michishita I; TRUTH Investigators.

Coron Artery Dis. 2013 Sep;24(6):481-6. doi: 10.1097/MCA.0b013e32836325ac.

PMID:
23751736
12.

HMG-CoA reductase inhibitor (Statin) therapy and coronary atherosclerosis in Japanese subjects: role of high-density lipoprotein cholesterol.

Tani S, Nagao K, Hirayama A.

Am J Cardiovasc Drugs. 2011 Dec 1;11(6):411-7. doi: 10.2165/11594620-000000000-00000.

PMID:
22149320
13.

Comparison of effects of serum n-3 to n-6 polyunsaturated fatty acid ratios on coronary atherosclerosis in patients treated with pitavastatin or pravastatin undergoing percutaneous coronary intervention.

Nozue T, Yamamoto S, Tohyama S, Fukui K, Umezawa S, Onishi Y, Kunishima T, Sato A, Nozato T, Miyake S, Takeyama Y, Morino Y, Yamauchi T, Muramatsu T, Hibi K, Terashima M, Michishita I.

Am J Cardiol. 2013 Jun 1;111(11):1570-5. doi: 10.1016/j.amjcard.2013.01.327. Epub 2013 Mar 13.

PMID:
23497779
14.

Plasma pentraxin-3 levels are associated with coronary plaque vulnerability and are decreased by statin.

Iwata A, Miura S, Tanaka T, Ike A, Sugihara M, Nishikawa H, Kawamura A, Saku K.

Coron Artery Dis. 2012 Aug;23(5):315-21. doi: 10.1097/MCA.0b013e328352ffec.

PMID:
22617341
15.

Correlations between serum uric acid and coronary atherosclerosis before and during statin therapy.

Nozue T, Yamamoto S, Tohyama S, Fukui K, Umezawa S, Onishi Y, Kunishima T, Hibi K, Terashima M, Michishita I.

Coron Artery Dis. 2014 Jun;25(4):343-8. doi: 10.1097/MCA.0000000000000084.

PMID:
24448173
16.

Impact of diabetes mellitus on coronary atherosclerosis and plaque composition under statin therapy – subanalysis of the TRUTH study –.

Nozue T, Yamamoto S, Tohyama S, Fukui K, Umezawa S, Onishi Y, Kunishima T, Sato A, Nozato T, Miyake S, Takeyama Y, Morino Y, Yamauchi T, Muramatsu T, Hibi K, Terashima M, Michishita I; TRUTH Investigators.

Circ J. 2012;76(9):2188-96. Epub 2012 Jun 12.

18.

Effect of statin therapy on the progression of coronary atherosclerosis.

Tian J, Gu X, Sun Y, Ban X, Xiao Y, Hu S, Yu B.

BMC Cardiovasc Disord. 2012 Sep 1;12:70. doi: 10.1186/1471-2261-12-70. Review.

19.

Pigment epithelium-derived factor is associated with necrotic core progression during statin therapy.

Nozue T, Yamagishi S, Hirano T, Yamamoto S, Tohyama S, Fukui K, Umezawa S, Onishi Y, Kunishima T, Hibi K, Terashima M, Michishita I.

Coron Artery Dis. 2015 Mar;26(2):107-13. doi: 10.1097/MCA.0000000000000192.

PMID:
25356816
20.

Clustering of metabolic syndrome components attenuates coronary plaque regression during intensive statin therapy in patients with acute coronary syndrome: the JAPAN-ACS subanalysis study.

Takashima H, Ozaki Y, Morimoto T, Kimura T, Hiro T, Miyauchi K, Nakagawa Y, Yamagishi M, Daida H, Mizuno T, Asai K, Kuroda Y, Kosaka T, Kuhara Y, Kurita A, Maeda K, Amano T, Matsuzaki M; JAPAN-ACS Investigators.

Circ J. 2012;76(12):2840-7. Epub 2012 Sep 7.

Items per page

Supplemental Content

Write to the Help Desk